Pages that link to "Q36571171"
Jump to navigation
Jump to search
The following pages link to Effects of D-cycloserine on extinction: translation from preclinical to clinical work (Q36571171):
Displaying 50 items.
- Angiotensin type 1 receptor inhibition enhances the extinction of fear memory (Q21710697) (← links)
- Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder (Q22242989) (← links)
- Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders (Q24187995) (← links)
- NMDA receptors and fear extinction: implications for cognitive behavioral therapy (Q24604822) (← links)
- Cognitive behavioral therapy in anxiety disorders: current state of the evidence (Q24604852) (← links)
- Positive allosteric modulation of mGluR5 receptors facilitates extinction of a cocaine contextual memory (Q24617217) (← links)
- D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning (Q24626679) (← links)
- Glutamatergic substrates of drug addiction and alcoholism (Q24648924) (← links)
- A hippocampal Cdk5 pathway regulates extinction of contextual fear (Q24649571) (← links)
- D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review (Q26781321) (← links)
- From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders (Q26851172) (← links)
- Towards medication-enhancement of cognitive interventions in schizophrenia (Q26860777) (← links)
- Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches. (Q27300710) (← links)
- Extinction circuits for fear and addiction overlap in prefrontal cortex (Q28241943) (← links)
- Fear extinction as a model for translational neuroscience: ten years of progress (Q28254365) (← links)
- Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity (Q28297186) (← links)
- Individual differences in recovery from traumatic fear (Q28389310) (← links)
- Promising avenues of therapeutics for bipolar illness (Q28744502) (← links)
- A Memory Retrieval-Extinction Procedure to Prevent Drug Craving and Relapse (Q28972241) (← links)
- Neural mechanisms of extinction learning and retrieval (Q29616240) (← links)
- Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy. (Q30358603) (← links)
- Fear-Potentiated Startle and Fear Extinction in a Sample of Undergraduate Women Exposed to a Campus Mass Shooting. (Q30365336) (← links)
- Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data (Q30382252) (← links)
- Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. (Q30387014) (← links)
- d-Cycloserine augmentation of cognitive remediation in schizophrenia (Q30404599) (← links)
- Microendophenotypes of psychiatric disorders: phenotypes of psychiatric disorders at the level of molecular dynamics, synapses, neurons, and neural circuits (Q30409099) (← links)
- Treating the developing brain: implications from human imaging and mouse genetics (Q30416107) (← links)
- The role of the medial prefrontal cortex in regulating social familiarity-induced anxiolysis. (Q30417829) (← links)
- Placing prediction into the fear circuit (Q30424615) (← links)
- Effects of systemic administration of oxytocin on contextual fear extinction in a rat model of post-traumatic stress disorder. (Q30428026) (← links)
- Cholinergic blockade frees fear extinction from its contextual dependency (Q30443020) (← links)
- D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia (Q30450078) (← links)
- Tools for translational neuroscience: PTSD is associated with heightened fear responses using acoustic startle but not skin conductance measures (Q30460015) (← links)
- Pharmacological enhancement of fear reduction: preclinical models. (Q30462825) (← links)
- The age of anxiety: role of animal models of anxiolytic action in drug discovery (Q30462832) (← links)
- Stress modulation of cognitive and affective processes (Q30464319) (← links)
- Pharmacotherapy of PTSD: premises, principles, and priorities (Q30479154) (← links)
- D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms (Q30479274) (← links)
- The role of the bed nucleus of the stria terminalis in learning to fear. (Q30481125) (← links)
- Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior (Q30484413) (← links)
- mGluR5 has a critical role in inhibitory learning. (Q30486477) (← links)
- Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference (Q30492380) (← links)
- Enhancing exposure-based therapy from a translational research perspective (Q30493574) (← links)
- Contextual-specificity of short-delay extinction in humans: renewal of fear-potentiated startle in a virtual environment (Q30496582) (← links)
- A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder (Q30498105) (← links)
- Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans (Q30525198) (← links)
- Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction (Q33626978) (← links)
- Sleep quality predicts treatment outcome in CBT for social anxiety disorder. (Q33704893) (← links)
- Psychobiology and molecular genetics of resilience (Q33707604) (← links)
- Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke. (Q33708292) (← links)